Günter Müller-Stewens
Thumbnail Image
Title
Prof. em. Dr.
Last Name
Müller-Stewens
First name
Günter
Email
guenter.mueller-stewens@unisg.ch
Phone
+41 71 224 2761
Homepage

Filters

11
Reset filters

Settings
Now showing 1 - 10 of 11
No Thumbnail Available
Publication

Private Equitisierung? Verlieren Konzerne den Wettbewerb um Eigentumsrechte gegenüber Private-Equity-Gesellschaften?

2010-02-20 , Brauer, Matthias , Müller-Stewens, Günter

View
No Thumbnail Available
Publication

Corporate Strategy & Governance

2009 , Müller-Stewens, Günter , Brauer, Matthias

View
No Thumbnail Available
Publication

从多元折价到多元溢价

2012 , Müller-Stewens, Günter , Brauer, Matthias

View
No Thumbnail Available
Publication

Neues Denken fördern

2008-06-16 , Brauer, Matthias , Müller-Stewens, Günter

View
No Thumbnail Available
Publication

Turning the conglomerate discount into a premium: a framework for corporate centers of multi-business firms

2010-01-20 , Brauer, Matthias , Müller-Stewens, Günter

View
No Thumbnail Available
Publication

Schafft unsere Konzernebene einen Mehrwert? Ein Plädoyer für eine verantwortungsvolle Diversifikation

2011 , Müller-Stewens, Günter , Brauer, Matthias , Eggers, Bernd , Ahlers, Friedel , Eichenberg, Timm

View
No Thumbnail Available
Publication

One-Firm-Strategien sind mehr als eine Modeerscheinung

2010-04-27 , Müller-Stewens, Günter , Brauer, Matthias

View
No Thumbnail Available
Publication

Synergien : Wie Synergienpotenzial optimal genutzt wird

2010-08-20 , Müller-Stewens, Günter , Brauer, Matthias

View
No Thumbnail Available
Publication

Building Innovation Networks in Biotechnology Industries

2006 , Brauer, Matthias , Müller-Stewens, Günter , Blecker, Thorsten , Gemünden, Hans Georg

This paper aims at developing a tentative guideline for managers of biotech firms on how to form and design network ties in biotechnology industries by integrating the findings from the analysis of the networking characteristics of the five leading biotechnology firms (Amgen, Biogen, Chiron, Genentech, Genzyme) with extant scholarly research on biotech networks, We derive a set of recommendations on salient process issues such as the timing, duration and design characteristics of both vertical (upstream, downstream) and horizontal network ties. Further, we generate insights into how biotech firms may develop their own organizational networking capability ("networkability") by making networking part of their business strategy, by creating networking-enhancing organizational structures and processes and by instilling network values in the organizational DNA. In doing so, we extend prior contributions on biotech networks and hope to create actionable knowledge for managers on how to build innovation networks.

View
No Thumbnail Available
Publication

Wie Synergiepotential optimal genutzt wird

2010 , Müller-Stewens, Günter , Brauer, Matthias

View